Health Stocks Hub (HSH) is 100% dedicated to publicly traded biotech, pharma, medical, and health technology stocks. We reach the web's largest and most targeted niche of investors specifically focused on identifying new investment opportunities within the life sciences sector and its associated industries. Our flexible campaigns allow companies to rapidly launch broad market awareness programs as well as deploy targeted investor outreach strategies across a variety of mediums and outlets:
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, today announced positive top-line data from its Phase 1 randomized, double-blind, placebo... Read More
Gain full exposure across the entire Health Stocks Hub platform through featured placement, branded news and stock quotes, banner rotation, featured profiles, video capsules, and much more.
